<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="2">35415812</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1437-160X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>42</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Rheumatology international</Title>
          <ISOAbbreviation>Rheumatol Int</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A better but persistently low health status in women with fibromyalgia during the COVID-19 pandemic: a repeated cross-sectional data analysis.</ArticleTitle>
        <Pagination>
          <StartPage>967</StartPage>
          <EndPage>972</EndPage>
          <MedlinePgn>967-972</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00296-022-05127-y</ELocationID>
        <Abstract>
          <AbstractText>Multiple overlapping and complementary theoretical arguments suggest that the COVID-19 pandemic could worsen health in fibromyalgia. The aim of this study was to determine mental and physical health in women with fibromyalgia before and during the pandemic. In a 3-sample, repeated cross-sectional design, we analyzed questionnaire data from Dutch women with fibromyalgia, collected in three independent samples: before the COVID-19 pandemic (2018; n = 142) and during the first acute (2020; n = 304) and prolonged (2021; n = 95) phases of the pandemic. Eight dimensions of mental and physical health were assessed using The RAND 36-Item Short Form Health Survey (RAND SF-36). Compared to norm group data, both before and during the pandemic, women with fibromyalgia showed high levels of fatigue and pain and low levels of general health, social functioning, physical functioning, role physical functioning (d &gt; 1.2, very large effect sizes), role emotional functioning, and mental health (0.71 &lt; d &lt; 1.2, medium to large effect sizes). Contrary to theoretical expectation, levels at five health variables before vs. during the pandemic did not differ (p &gt; 0.05), and levels of pain (p &lt; 0.001), role physical functioning (p &lt; 0.001), and physical functioning (p = 0.03) (0.014 ≤ pη<sup>2</sup> ≤ 0.042, small effect sizes) reflected a healthier status during than before the pandemic. These findings indicate a somewhat better but persistently low health status in women with fibromyalgia during the pandemic. This suggests that the pandemic may include changed circumstances that are favorable for some women with fibromyalgia.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Koppert</LastName>
            <ForeName>Tim Y</ForeName>
            <Initials>TY</Initials>
            <Identifier Source="ORCID">0000-0002-3194-6670</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Psychology, Bachelor Education Unit, Leiden University, Wassenaarseweg 52, 2333 AK, Leiden, The Netherlands. t.y.koppert@FSW.Leidenuniv.nl.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Middendorp</LastName>
            <ForeName>Henriët</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0003-4575-0895</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Psychology, Health, Medical, and Neuropsychology Unit, Leiden University, Leiden, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Geenen</LastName>
            <ForeName>Rinie</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0002-6615-6708</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, Utrecht University, Utrecht, The Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Altrecht Psychosomatic Medicine, Zeist, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Rheumatol Int</MedlineTA>
        <NlmUniqueID>8206885</NlmUniqueID>
        <ISSNLinking>0172-8172</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000078332" MajorTopicYN="N">Data Analysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005356" MajorTopicYN="Y">Fibromyalgia</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword>
        <Keyword MajorTopicYN="N">Fatigue</Keyword>
        <Keyword MajorTopicYN="N">Fibromyalgia</Keyword>
        <Keyword MajorTopicYN="N">Mental health</Keyword>
        <Keyword MajorTopicYN="N">Pain</Keyword>
        <Keyword MajorTopicYN="N">Physical health</Keyword>
      </KeywordList>
      <CoiStatement>No conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>5</Hour>
          <Minute>38</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35415812</ArticleId>
        <ArticleId IdType="pmc">PMC9005022</ArticleId>
        <ArticleId IdType="doi">10.1007/s00296-022-05127-y</ArticleId>
        <ArticleId IdType="pii">10.1007/s00296-022-05127-y</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912–920. doi: 10.1016/S0140-6736(20)30460-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(20)30460-8</ArticleId>
            <ArticleId IdType="pmc">PMC7158942</ArticleId>
            <ArticleId IdType="pubmed">32112714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shanthanna H, Strand NH, Provenzano DA, Lobo CA, Eldabe S, Bhatia A, Wegener J, Curtis K, Cohen SP, Narouze S. Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel. Anaesthesia. 2020;75:935–944. doi: 10.1111/anae.15076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/anae.15076</ArticleId>
            <ArticleId IdType="pmc">PMC7262200</ArticleId>
            <ArticleId IdType="pubmed">32259288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geenen R, Dures E. A biopsychosocial network model of fatigue in rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 2019;58:v10–v21. doi: 10.1093/rheumatology/kez403.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/kez403</ArticleId>
            <ArticleId IdType="pmc">PMC6827269</ArticleId>
            <ArticleId IdType="pubmed">31682275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee YC, Nassikas NJ, Clauw DJ. The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia. Arthritis Res Ther. 2011;13:211. doi: 10.1186/ar3306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/ar3306</ArticleId>
            <ArticleId IdType="pmc">PMC3132050</ArticleId>
            <ArticleId IdType="pubmed">21542893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sluka KA, Clauw DJ. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience. 2016;338:114–129. doi: 10.1016/j.neuroscience.2016.06.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2016.06.006</ArticleId>
            <ArticleId IdType="pmc">PMC5083139</ArticleId>
            <ArticleId IdType="pubmed">27291641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Serrano-Ibáñez ER, Esteve R, Ramírez-Maestre C, Ruiz-Párraga GT, López-Martínez AE. Chronic pain in the time of COVID-19: stress aftermath and central sensitization. Br J Health Psychol. 2021;26:544–552. doi: 10.1111/bjhp.12483.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bjhp.12483</ArticleId>
            <ArticleId IdType="pubmed">33099793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colas C, Jumel A, Vericel MP, Barth N, Manzanares J, Goutte J, Fontana L, Féasson L, Hupin D, Guyot J. Understanding experiences of fibromyalgia patients involved in the fimouv study during COVID-19 lockdown. Front Psychol. 2021;12:645092. doi: 10.3389/fpsyg.2021.645092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fpsyg.2021.645092</ArticleId>
            <ArticleId IdType="pmc">PMC8329548</ArticleId>
            <ArticleId IdType="pubmed">34354626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schweiger V, Secchettin E, Perini G, Martini A, Donadello K, Gottin L, Balzo G, Varrassi G, Polati E. Quality of life and psychological assessment in patients with Fibromyalgia Syndrome during COVID-19 pandemic in Italy: prospective observational study. Signa Vitae. 2022;18:41–46. doi: 10.22514/sv.2021.127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.22514/sv.2021.127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batres-Marroquín AB, Medina-García AC, Vargas Guerrero A, Barrera-Villalpando MI, Martínez-Lavín M, Martínez-Martínez LA. Effect of COVID-19 pandemic lockdown on fibromyalgia symptoms. J Clin Rheumatol. 2022;28:e289–e291. doi: 10.1097/RHU.0000000000001685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/RHU.0000000000001685</ArticleId>
            <ArticleId IdType="pmc">PMC8745953</ArticleId>
            <ArticleId IdType="pubmed">33264250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cavalli G, Cariddi A, Ferrari J, Suzzi B, Tomelleri A, Campochiaro C, De Luca G, Baldissera E, Dagna L. Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients. Rheumatology (Oxford) 2021;60:465–467. doi: 10.1093/rheumatology/keaa738.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/keaa738</ArticleId>
            <ArticleId IdType="pmc">PMC7717382</ArticleId>
            <ArticleId IdType="pubmed">33188686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rivera J, Castrejón I, Vallejo-Slocker L, Offenbächer M, Molina-Collada J, Trives L, López K, Caballero L, Hirsch JK, Toussaint L, Nieto JC, Alvaro-Gracia JM, Vallejo MA. Clinical impact of confinement due to the COVID-19 pandemic on patients with fibromyalgia: a cohort study. Clin Exp Rheumatol. 2021;39(Suppl 130):78–81. doi: 10.55563/clinexprheumatol/7lbz8n.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.55563/clinexprheumatol/7lbz8n</ArticleId>
            <ArticleId IdType="pubmed">33734969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iannuccelli C, Lucchino B, Gioia C, Dolcini G, Favretti M, Franculli D, Di Franco M. Mental health and well-being during the COVID-19 pandemic: stress vulnerability, resilience and mood disturbances in fibromyalgia and rheumatoid arthritis. Clin Exp Rheumatol. 2021;39(Suppl 130):153–160. doi: 10.55563/clinexprheumatol/4nb0ku.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.55563/clinexprheumatol/4nb0ku</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koppert TY, Jacobs JWG, Lumley MA, Geenen R. The impact of COVID-19 stress on pain and fatigue in people with and without a central sensitivity syndrome. J Psychosom Res. 2021;151:110655. doi: 10.1016/j.jpsychores.2021.110655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpsychores.2021.110655</ArticleId>
            <ArticleId IdType="pmc">PMC8553422</ArticleId>
            <ArticleId IdType="pubmed">34739944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>VanderZee KI, Sanderman R, Heyink JW, De Haes H. Psychometric qualities of the RAND 36-item health survey 1.0: a multidimensional measure of general health status. Int J Behav Med. 1996;3:104–122. doi: 10.1207/s15327558ijbm0302_2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1207/s15327558ijbm0302_2</ArticleId>
            <ArticleId IdType="pubmed">16250758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim HY. Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod. 2013;38:52–54. doi: 10.5395/rde.2013.38.1.52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5395/rde.2013.38.1.52</ArticleId>
            <ArticleId IdType="pmc">PMC3591587</ArticleId>
            <ArticleId IdType="pubmed">23495371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sawilowsky S. New effect size rules of thumb. J Mod Appl Stat Methods. 2009;8:26. doi: 10.22237/jmasm/1257035100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.22237/jmasm/1257035100</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
